首页> 美国卫生研究院文献>Frontiers in Pharmacology >Evaluation of Prophylactic and Therapeutic Effects of Tramadol and Tramadol Plus Magnesium Sulfate in an Acute Inflammatory Model of Pain and Edema in Rats
【2h】

Evaluation of Prophylactic and Therapeutic Effects of Tramadol and Tramadol Plus Magnesium Sulfate in an Acute Inflammatory Model of Pain and Edema in Rats

机译:曲马多和曲马多加硫酸镁在急性疼痛和水肿炎症模型中的预防和治疗作用评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background: Inflammatory pain is the most commonly treated clinical pain, since it develops following trauma or surgery, and accompanies rheumatic or arthritic diseases. Tramadol is one of the most frequently used opioid analgesics in acute and chronic pain of different origin. Magnesium is a widely used dietary supplement that was recently shown to be a safe analgesic drug in different models of inflammatory pain.Aim: This study aimed to evaluate the effects of systemically or locally injected tramadol with/without systemically injected magnesium sulfate in prophylactic or therapeutic protocols of application in a rat model of somatic inflammation.Methods: Inflammation of the rat hind paw was induced by an intraplantar injection of carrageenan (0.1 ml, 0.5%). The antihyperalgesic/antiedematous effects of tramadol (intraperitoneally or intraplantarly injected), and tramadol-magnesium sulfate (subcutaneously injected) combinations were assessed by measuring the changes in paw withdrawal thresholds or paw volume induced by carrageenan. The drugs were administered before or after inflammation induction.Results: Systemically administered tramadol (1.25–10 mg/kg) before or after induction of inflammation reduced mechanical hyperalgesia and edema with a maximal antihyperalgesic/antiedematous effect of about 40–100%. Locally applied tramadol (0.125 mg/paw) better reduced edema (50–100%) than pain (20–50%) during 24 h. Administration of a fixed dose of tramadol (1.25 mg/kg) with different doses of magnesium led to a dose-dependent enhancement and prolongation of the analgesic effect of tramadol both in prevention and treatment of inflammatory pain. Magnesium increases the antiedematous effect of tramadol in the prevention of inflammatory edema while reducing it in treatment.Conclusion: According to results obtained in this animal model, systemic administration of low doses of tramadol and magnesium sulfate given in combination is a potent, effective and relatively safe therapeutic option for prevention and especially therapy of somatic inflammatory pain. The best result is achieved when tramadol is combined with magnesium sulfate at a dose that is equivalent to the average human recommended daily dose and when the drugs are administered when inflammation is maximally developed.
机译:背景:炎性疼痛是最常治疗的临床疼痛,因为它是在创伤或手术后发展并伴随风湿性或关节炎性疾病而发展的。曲马多是不同来源的急性和慢性疼痛中最常用的阿片类镇痛药之一。镁是一种广泛使用的膳食补充剂,最近被证明在不同的炎症性疼痛模型中都是安全的镇痛药。目的:该研究旨在评估全身或局部全身或不全身使用曲马多的效果方法:通过足底注射角叉菜胶(0.1 ml,0.5%)诱导大鼠后爪发炎。曲马多(腹膜内或plant内注射)和曲马多-硫酸镁(皮下注射)的组合通过测量角叉菜胶诱导的爪缩回阈值或爪体积的变化来评估其抗痛觉过敏/镇痛作用。 结果:在炎症诱发之前或之后全身性给予曲马多(1.25-10 mg / kg)可以减轻机械痛觉过敏和水肿,最大的抗痛觉过敏/抗水肿作用约为40-100%。在24小时内,局部应用曲马多(0.125 mg /爪)减轻水肿(50-100%)优于减轻疼痛(20-50%)。固定剂量的曲马多(1.25 mg / kg)与不同剂量的镁的给药导致曲马多在预防和治疗炎性疼痛方面的剂量依赖性增强和延长了镇痛作用。镁可增强曲马多在预防炎症性水肿方面的抗水肿作用,同时减少其治疗。结论:根据该动物模型获得的结果,低剂量的曲马多与硫酸镁联合全身给药是预防,尤其是治疗躯体性炎性疼痛的有效,有效且相对安全的治疗选择。当曲马多与硫酸镁以等于人类平均每日推荐剂量的剂量联合使用时,以及在发炎程度最大时给药时,可获得最佳结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号